Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Journal of Travel Medicine|September 26, 2019
Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysisAndrea K Boggild, Eric Caumes, Martin P Grobusch, et al.Science Translational Medicine|April 19, 2016
The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge modelBeth D Kirkpatrick, Stephen S Whitehead, Kristen K Pierce, et al.Journal of Travel Medicine|September 12, 2018
Illness among US resident student travellers after return to the USA: a GeoSentinel analysis, 2007-17Kristina M Angelo, N Jean Haulman, Anne C Terry, et al.American Journal of Public Health|August 2, 2003
Innovative surveillance methods for rapid detection of disease outbreaks and bioterrorism: results of an interagency workshop on health indicator surveillanceJulie A Pavlin, Farzad Mostashari, Mark G Kortepeter, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2021
Remdesivir for the Prevention of Invasive Mechanical Ventilation or Death in Coronavirus Disease 2019 (COVID-19): A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort DataCatharine I Paules, Shannon K Gallagher, Rekha R Rapaka, et al.The Journal of Infectious Diseases|January 19, 2013
A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trialAnna P Durbin, Beth D Kirkpatrick, Kristen K Pierce, et al.The American Journal of Tropical Medicine and Hygiene|May 16, 2018
Leptospirosis among Returned Travelers: A GeoSentinel Site Survey and Multicenter Analysis-1997-2016Sophia G de Vries, Benjamin J Visser, Rhett J Stoney, et al.Plos Neglected Tropical Diseases|May 9, 2017
In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccinationStephen S Whitehead, Anna P Durbin, Kristen K Pierce, et al.Journal of Travel Medicine|March 30, 2017
Clostridium difficile infection in returning travellersA Michal Stevens, Douglas H Esposito, Rhett J Stoney, et al.Plos One|October 18, 2016
Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve AdultsKawsar R Talaat, Ruth D Ellis, Janet Hurd, et al.Pageof 3